OBJECTIVES: A prospective, open study of @entity572 ( @entity572 ) was performed to determine if different radiological patterns of @entity625 vary in their response. METHODS: Forty five @entity1 (15 with @entity309 , 27 with @entity571 , and three with @entity1511 ) underwent hip injection with 80 mg @entity1667 and @entity3303 under x ray control. Outcome was assessed at two, 12, and 26 weeks for @entity158 , range of hip movement, and graded functional questionnaire. @entity1 estimated their @entity158 in four components, night @entity158 , @entity158 , weight bearing, and referred @entity158 , each measured by 10 cm visual analogue score and summed to give a total score out of 40 cm. Hip radiographs were evaluated blindly for pattern and severity of @entity625 , as well as for progression between 0 and 26 weeks. RESULTS: Median @entity158 score decreased from 29 cm at baseline to 22 cm at two weeks (p = 0.0001), 24 cm at 12 weeks (p = 0.03), but had returned nearly to baseline by 26 weeks (25 cm, p = 0.3). Greatest improvement was seen for night @entity158 . Mean range of internal rotation increased from 16 to 28 degrees at two weeks (p = 0.03) and 21 degrees at 12 weeks (p = 0.06). Functional ability did not change. Hips with an @entity3202 pattern of @entity625 on plain radiography gained negligible @entity158 relief at two weeks compared with hips with a @entity1184 or mixed bone response (p = 0.04). The degree of @entity158 relief was similar in @entity1 with @entity571 and @entity309 , and was not influenced by radiographic severity or by the direction of migration of the femoral head. CONCLUSION: @entity158 and internal rotation improve for up to 12 weeks after @entity572 . @entity572 offers a useful and safe therapeutic option for @entity1 with @entity625 , with the exception of those with a purely @entity3202 radiological pattern.

Radiographic patterns and response to XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity1667 :: ('MESH:D008775', 'Chemical') :: ['methylprednisolone'] @entity625 :: ('MESH:D001168', 'Disease') :: ['hip arthritis', 'arthritis'] @entity571 :: ('MESH:D010003', 'Disease') :: ['osteoarthritis', 'OA'] @entity1184 :: ('MESH:D006984', 'Disease') :: ['hypertrophic'] @entity3202 :: ('MESH:D016109', 'Disease') :: ['atrophic'] @entity1511 :: ('MESH:D013166', 'Disease') :: ['anklyosing spondylitis'] @entity3303 :: ('MESH:D008012', 'Chemical') :: ['lignocaine'] @entity572 :: ('MESH:D006617', 'Disease') :: ['corticosteroid hip injection', 'CHI'] @entity158 :: ('MESH:D010146', 'Disease') :: ['rest pain', 'Pain', 'pain', 'total pain'] @entity309 :: ('MESH:D001172', 'Disease') :: ['rheumatoid arthritis', 'RA']
@entity572 :: (MESH:D006617,Disease) :: ['corticosteroid hip injection']
